Therapeutic hypothermia for mild neonatal encephalopathy: a systematic review and meta-analysis. Issue 2 (19th December 2018)

• Record Type: Journal Article
• Authors: Kariholu, Ujwal; Montaldo, Paolo; Markati, Theodora; Lally, Peter J; Pryce, Russell; Teiserskas, Justinas; Liow, Natasha; Oliveira, Vânia; Soe, Aung; Shankaran, Seetha; Thayyil, Sudhin
• Is Part Of: Archives of disease in childhood. Volume 105:Issue 2(2020)
• Page Start: 225
• Page End: 228
• Publication Date: 2018-12-19
• Subjects: hypoxic ischaemic encephalopathy -- therapeutic hypothermia -- meta-analysis -- newborn; Infants -- Diseases -- Periodicals; Newborn infants -- Diseases -- Periodicals; Fetus -- Diseases -- Periodicals; 618.920105
• DOI: 10.1136/archdischild-2018-315711
• Languages: English
• ISSNs: 1359-2998

Abstract

Abstract : Objectives: To examine if therapeutic hypothermia reduces the composite outcome of death, moderate or severe disability at 18 months or more after mild neonatal encephalopathy (NE). Data source: MEDLINE, Cochrane database, Scopus and ISI Web of Knowledge databases, using 'hypoxic ischaemic encephalopathy', 'newborn' and 'hypothermia', and 'clinical trials' as medical subject headings and terms. Manual search of the reference lists of all eligible articles and major review articles and additional data from the corresponding authors of selected articles. Study selection: Randomised and quasirandomised controlled trials comparing therapeutic hypothermia with usual care. Data extraction: Safety and efficacy data extracted independently by two reviewers and analysed. Results: We included the data on 117 babies with mild NE inadvertently recruited to five cooling trials (two whole-body cooling and three selective head cooling) of moderate and severe NE, in the meta-analysis. Adverse outcomes occurred in 11/56 (19.6%) of the cooled babies and 12/61 (19.7%) of the usual care babies (risk ratio 1.11 (95% CIs 0.55 to 2.25)). Conclusions: Current evidence is insufficient to recommend routine therapeutic hypothermia for babies with mild encephalopathy and significant benefits or harm cannot be excluded.